Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Fall 2021 RFP: Outcome Measures, 2022
    Using RNA from Extracellular Vesicles to Monitor RNA Changes in the Brain

    Study Rationale: Our understanding of Parkinson’s disease (PD) would be significantly improved if we had a way to directly monitor disease development and progression in the brain. One approach is to...

  • Diversity, Equity and Inclusivity in Parkinson's research, 2022
    Understanding the Progression of Motor and Non-motor Symptoms and Functional Mobility of Māori and Pacific Peoples in New Zealand

    Study Rationale: In this study, we will work with two underrepresented groups in Aotearoa, New Zealand, the Māori and Pacific peoples. By better understanding the clinical presentation of Parkinson’s...

  • Fall 2021 RFP: Outcome Measures, 2022
    Development of Standardized Measurements for Monitoring the Progression of Parkinson’s Disease via MRI

    Study Rationale: One of the difficulties in research towards new treatments in Parkinson’s disease (PD) is the diversity of disease presentations and the lack of tools to measure the effect of a...

  • , 2022
    Studying the Epidemiology of Parkinson’s Disease in Latin America: Learning from Underrepresented Populations

    Study Rationale: Initial evidence has shown that the global distribution of Parkinson’s disease (PD) may vary; however, little is known about the prevalence of PD across large parts of the world. This...

  • Diversity, Equity and Inclusivity in Parkinson's research, 2022
    Risk Factors for Parkinson’s Disease Among Participants in the Black Women’s Health Study

    Study Rationale: Little is known about the incidence, clinical presentation and risk factors for Parkinson’s disease (PD) in Black women, yet the existing evidence suggest that they may have a worse...

  • Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies, 2022
    Using “Nanobodies” to Prevent Formation of Intracellular Alpha-synuclein Aggregates

    Study Rationale: The aggregation of a structurally abnormal form of the protein alpha-synuclein appears to be responsible for the initiation and progression of Parkinson’s disease (PD). In previous...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.